Charles River Laboratories International, Inc. (CRL) News

Charles River Laboratories International, Inc. (CRL): $219.46

1.96 (+0.90%)

POWR Rating

Component Grades













Filter CRL News Items

CRL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CRL News Highlights

  • CRL's 30 day story count now stands at 40.
  • Over the past 21 days, the trend for CRL's stories per day has been choppy and unclear. It has oscillated between 1 and 23.
  • The most mentioned tickers in articles about CRL are BEAT, BIO and TNDM.

Latest CRL News From Around the Web

Below are the latest news stories about Charles River Laboratories International Inc that investors may wish to consider to help them evaluate CRL as an investment opportunity.

3 Moonshot Stocks Insiders Are Buying. What Do They Know?

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares.

Thomas Yeung on InvestorPlace | February 25, 2022

Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish

The acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm.

Yahoo | February 22, 2022

Here's Why We Think Charles River Laboratories International (NYSE:CRL) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | February 19, 2022

Analysts Offer Insights on Services Companies: Charles River Labs (CRL), Cheesecake Factory (CAKE) and Trade Desk (TTD)

There's a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Charles River Labs (CRL – Research Report), Cheesecake Factory (CAKE – Research Report) and Trade Desk (TTD – Research Report) with bullish sentiments. Charles River Labs (CRL) In a report released today, Donald Hooker from KeyBanc maintained a Buy rating on Charles River Labs, with a price target of $390.00. The company's shares closed last Wednesday at $305.28. Hooker has an average return of 13.7% and a 52.6% success rate. Patterson covers the Technology sector, focusing on stocks such as NerdWallet, Inc. Class A, Spotify Technology SA, and Alphabet Class A.

Catie Powers on TipRanks | February 17, 2022

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.

Yahoo | February 17, 2022

Tandem Diabetes (TNDM) to Offer Insulin Delivery With Smartphone

Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive FDA clearance for insulin delivery from a personal smartphone.

Yahoo | February 17, 2022

Charles River''s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Charles River Laboratories International Inc''s (NYSE: CRL ) Q4 sales increased 14.4% Y/Y to $905.1 million , beating the consensus of $888.27 million. Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and … Full story available on

Benzinga | February 16, 2022

Charles River Laboratories International, Inc. (CRL) CEO James Foster on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 16, 2022

Charles River stock falls after Q4 results; Baird calls Q1 guidance ''light''

Charles River Laboratories International <> stock declined following its Q4 results, which beat analysts'' estimates, and reaffirming its 2022 Guidance.Q4 total revenue increased…

Seeking Alpha | February 16, 2022

Charles River Laboratories International, Inc. 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 16, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4293 seconds.